|
 Major League Baseball’s collectively bargained drug policy has undergone changes, adding 12 new performance-enhancing drugs, and 30 new stimulants that players will be tested for, according to a memo obtained by The Biz of Baseball.
The memo, placed on the door of each Spring Training clubhouse, adds the following to Section 2.B of the Joint Drug Prevention and Treatment Program on performance-enhancing drugs:
|
1. Androstatrienedione (ATD)
|
9. Methasterone (Superdrol)
|
|
2. Androstadienedione
|
10. Methylnortestosterone
|
|
3. Androstenetrione (6-OXO)
|
11. Methyltrienelone (Metribolone)
|
|
4. Androsterone
|
12. Anabolic Agents:
a. Selective Androgen Receptor
Modulators (SARMs)
b. Tibolone
c. Zeranol
d. Zilpaterol
|
|
5. Bolandiol
|
|
6. Epiandrosterone
|
|
7. Epi-dihydrotestosterone
|
|
8. Epitestosterone
|
In terms of stimulants, players will see a considerable increase in the number of substances that players could potentially be suspended for. Added to the list of Stimulants set forth in Section 2.C of the JDA include:
|
1. Adrafinil
|
16. Methamphetamine (Methylamphetamine)
|
|
2. Amiphenazole
|
17. Methylenedioxy-amphetamine
|
|
3. Benzylpiperazine
|
18. Methylenedioxymethamphetamine
|
|
4. Bromantan
|
19. Methylephedrine
|
|
5. Carphedon
|
20. Nikethamide
|
|
6. Cathine (Norpseudoephedrine)
|
21. Norfenefrine
|
|
7. Croprapamide
|
22. Norfenfluramine
|
|
8. Crotetamide
|
23. Octopamine
|
|
9. Etamivan
|
24. Oxilofrine
|
|
10. Etilefrine
|
25. Parahydroxyamphetamine
|
|
11. Fenbutrazate
|
26. Pentetrazol
|
|
12. Heptaminol
|
27. Phepromethamine
|
|
13. Isometheptene
|
28. Prenylamine
|
|
14. Levmetamphetamine
|
29. Sibutramine
|
|
15. Meclofenoxate
|
30. Tuaminoheptane
|
The memo dated Feb 19th states that the additional substances being tested for are effective Spring Training of 2010.
The memo was jointly released by MLB and the MLBPA and signed by Rob Manfred, Jr., the Executive Vice President of Major League Baseball; Michael Weiner, Executive Director of the MLB Players Association; Dan Halem, MLB’s Senior Vice President and General Counsel; Bob Lenaghan, MLBPA Assistant General Counsel; Jon Coyles, director of baseball’s drug policy; Dr. Bryan Smith, the Independent Program Administrator for the Program, and; Christiane Ayotte, an anti-doping expert at the Quebec-based National Institute for Scientific Research who is in charge of a special anti-doping laboratory set up for the Vancouver 2010 Olympic Games.
 Maury Brown is the Founder and President of the Business of Sports Network, which includes The Biz of Baseball, The Biz of Football, The Biz of Basketball and The Biz of Hockey. He is available for hire or freelance. Brown's full bio is here. He looks forward to your comments via email and can be contacted through the Business of Sports Network.
Follow Maury Brown on Twitter 
Follow The Biz of Baseball on Twitter
 Follow the Business of Sports Network on Facebook
|
Subscribe to this comment's feed
